SLC7A5 and retinoblastoma: Through directly targeting SLC7A5, miR-184 inhibits proliferation, migration, and invasion and enhances impairment of DNA damage repair (G2/M phase arrest) and cellular apoptosis of RB cells exposed to chemotherapeutic drugs.